Why We Must Finish Our Antibiotics

  23 April 2019

Consultant infectious disease physician Dr Sasheela Sri La Sri Ponnampalavanar highlighted the “Review on Antimicrobial Resistance (AMR)” by Amsterdam-based research programme AMR Benchmark that estimated 10 million people will die from resistance to antimicrobial medicines like antibiotics and antifungals by 2050, higher than the current combined deaths for cancer, diabetes, and road traffic accidents. 

Further reading: Code Blue
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Evotec

JSS University

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!